InsiderInsights.com Daily Round Up 7/19/16: Virtus Total Return Fund, Nuveen Global Equity Income Fund

|
Includes: AFAM, CBSH, CONN, DCA, DRII, FB, INFO, JGV, LNG, N, OSTK, RARE, RNVA, SYK, TTNP
by: InsiderInsights

Summary

Tables of the top insider purchases and sales filed with the SEC on 7/19/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

Educational note from InsiderInsights:

Insider filing volumes are at a seasonal low point due to companies closing trading windows to their insiders until quarterly earnings are released. As a result, the dollar values of trades featured in our Daily round Up articles (particularly the purchases) will likely be lower than usual until early August.

On Today's Tables:

Insider trades were rated Significant at:

  • Nuveen Global Equity Income Fund (NYSE:JGV), and;
  • Virtus Total Return Fund (NYSE:DCA).

Insider trades were rated Nearly Significant at:

  • Reva Medical (RVA);
  • Conns (NASDAQ:CONN), and;
  • Ultragenyx Pharm (NASDAQ:RARE).

Insider trades were considered Insignificant at:

  • Titan Pharm (NASDAQ:TTNP);
  • Rennova Health (NASDAQ:RNVA);
  • Stryker (NYSE:SYK);
  • Netsuite (NYSE:N);
  • Facebook (NASDAQ:FB);
  • Commerce Banc (NASDAQ:CBSH), and;
  • Almost Family (NASDAQ:AFAM).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Overstock Com (NASDAQ:OSTK);
  • Cheniere Energy (NYSEMKT:LNG), and;
  • Diamond Resorts (NYSE:DRII).

There is an IPO or Known Corporate Action at:

  • Ihs Markit (NASDAQ:INFO).

It's difficult to argue significance for most transactions made during IPOs, or when insiders make trades during a known corporate action.

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Guggenheim Capital BO Diamond Resorts DRII B $37,976,640
2 Stephens Warren A BO Conns CONN JB* $7,100,000
3 Fusco Jack A CEO,DIR Cheniere Energy LNG AB $1,499,945
4 Simon Stormy PR,DIR Overstock Com OSTK JB* $1,187,200
5 Thomas Robert Bain DIR Reva Medical RVA JB* $224,205
6 Bulldog Investors BO Nuveen Global Equity Income Fund JGV B $183,096
7 Diamantis Christopher Eric DIR Rennova Health RNVA JB* $146,667
8 Keating Anne DIR Reva Medical RVA JB* $114,390
9 Bulldog Investors BO Virtus Total Return Fund DCA B $84,123
10 Akers Joseph A DIR Titan Pharm TTNP B $63,000
Click to enlarge

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales

#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Cloobeck Stephen J DIR,BO Diamond Resorts DRII S $18,988,320
2 Cox Christopher K O Facebook FB S $4,361,016
3 Stead Jerre L CEO,CB,DIR Ihs Markit INFO S $2,453,180
4 Kemper David W CB,CEO Commerce Banc CBSH S $1,954,384
5 North Tide Capital BO Almost Family AFAM S $1,737,533
6 Goldberg Evan CTO,CB,DIR Netsuite N AS $1,595,917
7 Stryker Ronda E DIR Stryker SYK AS $1,465,365
8 Byrne Patrick Michael CEO,DIR,BO Overstock Com OSTK JS* $1,187,200
9 Kakkis Emil D CEO,DIR Ultragenyx Pharm RARE AS $1,016,909
10 Fischer David B VP,SO,PT Facebook FB S $916,455
Click to enlarge

InsiderInsights.com | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Disclosure: I am/we are long DCA.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.